Survival Bias When Assessing Risk Factors for Age-Related Macular Degeneration: A Tutorial with Application to the Exposure of Smoking

Ophthalmic Epidemiology

Volumn 24, Issue 4, 2017, Pages 229-238

  McGuinness, Myra B ^a,b,c   Karahalios, Amalia ^b   Kasza, Jessica ^d   Guymer, Robyn H ^a,c   Finger, Robert P ^a,c,e   Simpson, Julie A ^b,f  

^a ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY OF BONN   (Germany)

^f CANCER EPIDEMIOLOGY CENTRE   (Australia)

Author keywords

Age related macular degeneration; causal methodology; death; smoking; survival bias

Indexed keywords

ADULT; AGE DISTRIBUTION; AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY ANALYSIS; SMOKING; STATISTICAL BIAS; SURVIVAL BIAS; SURVIVAL RATE; ADVERSE EFFECTS; CAUSE OF DEATH; CLINICAL TRIAL; EPIDEMIOLOGY; INCIDENCE; MACULAR DEGENERATION; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; ODDS RATIO; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; TRENDS; VERY ELDERLY; VICTORIA;

AGED; AGED, 80 AND OVER; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MACULAR DEGENERATION; MALE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SMOKING; SURVIVAL RATE; VICTORIA;

EID: 85015008978     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.1080/09286586.2016.1276934     Document Type: Article

References (35)

1. Gohdes DM, Balamurugan A, Larsen BA, et al. Age-related eye diseases:an emerging challenge for public health professionals. Prevent Chronic Dis 2005;2:1–6.
2. Cugati S, Cumming RG, Smith W, et al. Visual impairment, age-related macular degeneration, cataract, and long-term mortality–The Blue Mountains Eye Study. Arch Ophthalmol 2007;125:917–924.
3. Knudtson MD, Klein BEK, Klein R., Age-related eye disease, visual impairment, and survival–The Beaver Dam Eye Study. Arch Ophthalmol 2006;124:243–249.
4. Chew EY, Clemons TE, Agron E, et al. Long-term effects of vitamins C and E, beta-Carotene, and zinc on age-related macular degeneration AREDS report no. 35. Ophthalmology 2013;120:1604–1611.
5. Glymour MM, Weuve J, Chen JT., Methodological challenges in causal research on racial and ethnic patterns of cognitive trajectories:measurement, selection, and bias. Neuropsychol Rev 2008;18:194–213.
6. Thornton J, Edwards R, Mitchell P, et al. Smoking and age-related macular degeneration:a review of association. Eye 2005;19:935–944.
7. Banks E, Joshy G, Weber MF, et al. Tobacco smoking and all-cause mortality in a large Australian cohort study:findings from a mature epidemic with current low smoking prevalence. BMC Med 2015;13:281–290.
8. Fagerstrom K., The epidemiology of smoking–Health consequences and benefits of cessation. Drugs 2002;62:1–9.
9. Dawid AP., Causal inference without counterfactuals. J Am Statist Assn 2000;95(450):407–424.
10. Rubin DB., Causal inference without counterfactuals–Comment. J Am Statist Assn 2000;95(450):435–438.
11. Frangakis CE, Rubin DB., Principal stratification in causal inference. Biometrics 2002;58:21–29.
12. Zhang JL, Rubin DB., Estimation of causal effects via principal stratification when some outcomes are truncated by ‘death’. J Educat Behav Statist 2003;28:353–368.
13. Hayden D, Pauler DK, Schoenfeld D., An estimator for treatment comparisons among survivors in randomized trials. Biometrics 2005;61(1):305–310.
14. Egleston BL, Scharfstein DO, Freeman EE, et al. Causal inference for non-mortality outcomes in the presence of death. Biostatistics 2007;8:526–545.
15. Giles GG., The Melbourne study of diet and cancer. Proc Nutr Soc Aus 1990;15(1990):94–103.
16. Aung KZ, Robman L, Chong EWT, et al. Non-mydriatic digital macular photography:how good is the second eye photograph? Ophthalmic Epidemiol 2009;16:254–261.
17. Williamson EJ, Aitken Z, Lawrie J, et al. Introduction to causal diagrams for confounder selection. Respirology 2014;19:303–311.
18. Klein R., The prevalence of age-related eye diseases and visual impairment in aging:current estimates. Invest Ophthalmol Vis Sci 2013;54(14):ORSF5–ORSF13.
19. Amirul Islam FM, Chong EW, Hodge AM, et al. Dietary patterns and their associations with age-related macular degeneration:the Melbourne collaborative cohort study. Ophthalmology 2014;121:1428–1434.
20. Dandona R, Dandona L., Socioeconomic status and blindness. Br J Ophthalmol 2001;85:1484–1488.
21. Trichopoulou A, Costacou T, Bamia C, et al. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 2003;348:2599–2608.
22. ABS. Socio-economic indexes for areas (Seifa). ACT, Australia:Australian Bureau of Statistics, 2011.
23. Ferris FL, 3rd, Wilkinson CP, Bird A, et al. Clinical classification of age-related macular degeneration. Ophthalmology 2013;120:844–851.
24. Rubin DB., Estimating causal effects of treatments in randomized and nonrandomized studies. J Educat Psychol 1974;66:688–701.
25. Imbens GW, Angrist JD., Identification and estimation of local average treatment effects. Econometrica 1994;62:467–475.
26. Chiba Y., Estimation and sensitivity analysis of the survivor average causal effect under the monotonicity assumption. J Biomet Biostat 2012;3:116–118.
27. Chiba Y, VanderWeele TJ., A simple method for principal strata effects when the outcome has been truncated due to death. Am J Epidemiol 2011;173:745–751.
28. Rosenbaum PR, Rubin DB., The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41–55.
29. Rubin DB., Inference and missing data. Biometrika 1976;63:581–590.
30. Cox DR., Some problems connected with statistical inference. Ann Math Stat 1958;29:357–372.
31. Rubin DB., Randomization analysis of experimental data:the Fisher randomisation test–Comment. J Am Stat Assn 1980;75(371):591–593.
32. Mitchell P, Economics DA., Eyes on the future:a clear outlook on age-related macular degeneration. Sydney:Macular Degeneration Foundation, 2011.
33. Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040:a systematic review and meta-analysis. Lancet Global Health 2014;2:e106–e116.
34. Carpenter J, Bithell J., Bootstrap confidence intervals:when, which, what? A practical guide for medical statisticians. Stat Med 2000;19:1141–1164.
35. Robins JM., An analytic method for randomized trials with informative censoring:Part 1. Lifetime Data Anal 1995;1:241–254.